Related Experiment Videos
Re: "High-Content Screening Identifies New Inhibitors of Connexin 43 Gap Junctions" by Picoli et al. (Assay Drug Dev
1Executive Director, The Quinism Foundation, White River Junction, Vermont.
Assay and Drug Development Technologies
|November 23, 2019
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
FDA Black Box, VA Red Ink? A Successful Service-Connected Disability Claim for Chronic Neuropsychiatric Adverse Effects From Mefloquine.
Federal practitioner : for the health care professionals of the VA, DoD, and PHS·2019
Association of Poultry Processing Industry Exposures With Reports of Occupational Finger Amputations: Results of an Analysis of OSHA Severe Injury Report (SIR) Data.
Journal of occupational and environmental medicine·2017
A serious nightmare: psychiatric and neurologic adverse reactions to mefloquine are serious adverse reactions.
Pharmacology research & perspectives·2017
Thiolated Natural Gum-Based Drug Delivery Techniques and Their Efficiency in Diabetes Mellitus and Associated Carcinoma: Possibilities, Pathways, Applications, and Challenges.
Assay and drug development technologies·2026
In Vitro Interaction of Tacrolimus (FK506) with Conventional and Nanoformulated Antifungal Drugs Against Clinical Dermatophyte Isolates Including Trichophyton indotineae.
Assay and drug development technologies·2026
Antiangiogenic Effect of Pluchea lanceolata in Adjuvant-Induced Rheumatoid Arthritis in Wistar Rats by Downregulating VEGF Signaling Pathway and Proinflammatory Cytokines.
Assay and drug development technologies·2026
Integrated In Vivo and In Silico Approaches for Targeting JAK2/STAT3/SOCS3: Repurposing Boeravinone B and Resveratrol as Chemopreventive Agents in Colon Cancer.
Assay and drug development technologies·2026
Molecular Mechanisms and Optimization Strategies for the Impact of Antihypertensive, Lipid-Lowering, and Antidiabetic Drugs on Gut Microbiota.
Assay and drug development technologies·2026
Identification of Broad-Spectrum Inhibitors Targeting Multiple Amyloidogenic Proteins Using Functional Group-Based Virtual Screening.
Assay and drug development technologies·2026
Design, Synthesis, and Biological Evaluation of Anthracene Derivatives as Potent Antioxidants: Experimental, DFT, and Docking Studies.
Chemical biology & drug design·2026
Integrated in vitro and in silico evaluations of novel benzanilide derivatives as anticancer agents.
Future medicinal chemistry·2026
Total Synthesis-Assisted Structure Determination and Biological Evaluation of Cytotoxic Cyclodepsipeptide Destruxin F.
Chemical & pharmaceutical bulletin·2026
Syzygium aromaticum Attenuates Cerebellar Oxidative Stress: An Integrated in silico, in vitro, and in vivo Evaluation of Multi-Target Antioxidant Mechanisms.
Journal of experimental pharmacology·2026